Melanoma Research

Article	Citations
Temozolomide monotherapy versus combination therapies in melanoma: a meta-analysis of efficacy and safety	21
A comparison of myeloid-derived suppressor cell populations in patients with ulcerated vs non-ulcerated melanoma receiving immune checkpoint blockade	17
Genetic concordance in melanoma: insights from primary tumors and their matched distant metastases	17
Eruptive melanocytic nevi in a patient with amelanotic melanoma: a paraneoplastic phenomenon?	16
Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitors	16
Polymorphisms in toll-like receptor 3 and 4 genes as prognostic and outcome biomarkers in melanoma patients	12
Treatment reality of patients with BRAF-mutant advanced/metastatic melanoma in Switzerland in the era of choice	12
Histopathological and immunological spectrum in response evaluation of talimogene laherparepvec treatment and correlation with durable response in patients with cutaneous melanoma	11
Management of metastatic bone disease of melanoma	10
Targeting beta-adrenergic receptor pathways in melanoma: how stress modulates oncogenic immunity	10
Efficacy of topical diphencyprone for melanoma in-transit metastases: a systematic review and meta-analysis	10
Analysis of circulating tumor DNA during checkpoint inhibition in metastatic melanoma using a tumor-agnostic panel	10
Bone marrow metastases: a systematic review of a neglected involvement in malignant melanoma	10
Rare immune-related adverse events in a patient with metastatic melanoma: a case report highlighting sarcoidosis-like reactions triggered by immune-checkpoint inhibitors	10
Genetic causal relationship between gut microbiota and cutaneous melanoma: a two-sample Mendelian randomization study	10
Simultaneous melanomas in the setting of multiple primary melanomas	10
Immune-related adverse events are associated with therapeutic efficacy of immunotherapy in patients with melanoma brain metastases	9
Improved cutaneous melanoma survival stratification through integration of 31-gene expression profile testing with the American Joint Committee on Cancer 8th Edition Staging	9
Surgery of small bowel melanoma metastases in the era of efficient medical therapies: a retrospective cohort study	9
The importance of mitosis ≥2 in selecting patients with T1 cutaneous melanomas for sentinel lymph node biopsy	9
The inhibitory role of microRNA-141-3p in human cutaneous melanoma growth and metastasis through the fibroblast growth factor 13-mediated mitogen-activated protein kinase axis	8
Tumor mutational burden and somatic mutation status to predict disease recurrence in advanced melanoma	8
Prognosis of CDKN2A germline mutation in patients with familial melanoma: a systematic review and meta-analysis	8
High-resolution RNA-sequencing reveals TRIM33::CSDE1 gene fusion in metastasizing vulvar melanoma	8
ATF3 regulates CDC42 transcription and influences cytoskeleton remodeling, thus inhibiting the proliferation, migration and invasion of malignant skin melanoma cells	8

Clinicopathological demographics of malignant melanomas of the vulva and vagina in Japan	8
Aseptic cystitis induced by nivolumab and ipilimumab combination for metastatic melanoma	8
Telomere length is associated with increased risk of cutaneous melanoma: a Mendelian randomization study	8
Ponatinib-induced eruptive nevi and melanocytic proliferation	8
Lack of association between anatomical sites of scalp melanomas and brain metastases does not support direct vascular spread	7
The association between dermatologist density and melanoma prognosis using melanoma mortality-incidence ratio	7
Recurrent hemophagocytic lymphohistiocytosis in advanced melanoma treated with two different BRAF/MEK-inhibitor regimens	7
Anorectal melanoma: systematic review of the current literature of an aggressive type of melanoma	7
Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital setting	7
Screening costs associated with donor selection for fecal microbiota transplantation for treatment of PD-1 refractory melanoma patients	7
Regorafenib in patients with pretreated advanced melanoma: a single-center case series	7
Causal relationship between sex hormones and cutaneous melanoma: a two-sample Mendelian randomized study	7
Resistance to anti-PD1 therapies in patients with advanced melanoma: systematic literature review and application of the Society for Immunotherapy of Cancer Immunotherapy Resistance Taskforce anti-PD1	7
Development and validation of prognostic nomogram in pediatric melanoma: a population-based study	6
Clinical features, molecular characteristics and surgical management of primary penile mucosal melanoma based on the European Association of Urology Penile Cancer Guidelines	6
Study of clinical characteristics and risk factors for amelanotic/hypomelanotic melanoma in an Australian cohort	6
Management of cardiac metastases of melanoma in the era of immunotherapy: a case series	6
MeVa2.1.dOVA and MeVa2.2.dOVA: two novel BRAFV600E-driven mouse melanoma cell lines to study tumor immune resistance	6
Real-world outcomes of different lines and sequences of treatment in BRAF-positive advanced melanoma patients	6
Melanotransferrin is efficiently sorted on the surface of exosomes secreted by melanoma cells	6
Dacarbazine in the management of metastatic melanoma in the era of immune checkpoint therapy: a valid option or obsolete?	6
The human and animals’ malignant melanoma: comparative tumor models and the role of microbiome in dogs and humans	6
Updates on the diagnosis, current and future therapeutic options in Merkel-cell carcinoma	6
Efficiency and tolerance of second-line triple BRAF inhibitor/MEK inhibitor/anti-PD1 combined therapy in BRAF mutated melanoma patients with central nervous system metastases occurring during first-li	5
Melanocytic neoplasms in neurofibromatosis type 1: a systematic review	5
LS-007 inhibits melanoma growth via inducing apoptosis and cell cycle arrest and regulating macrophage polarization	5
Nodular type predominance of head and neck cutaneous malignant melanoma in Asian populations leads to poor outcome and low survival	5
Melanoma in the head and neck region: the value of preoperative imaging in melanoma stage I–II	5
Macrophage inhibitory cytokine-1 produced by melanoma cells contributes to melanoma tumor growth and metastasis in vivo by enhancing tumor vascularization	5
BRCA1-associated protein 1 c.368delG mutation leads to the development of multiple BAPomas and cutaneous melanomas: a novel pathogenic variant in BRCA1-associated protein tumor predisposition syndrome	5
Expression of the cancer stem cell marker OCT4 is associated with worse prognosis and survival in cutaneous melanoma	5
Immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies, in a patient with melanoma treated with BRAF/MEK inhibitors	5
Hypoxic transcriptomes predict survival and tumor-infiltrating immune cell composition in cutaneous melanoma	5
Assessment of lipid and pigment content in suspicious melanocytic lesions to improve melanoma detection	4
Rate of response to immune checkpoint inhibitor therapy in patients with conjunctival melanoma	4
DNA methylation of GITR, OX40, 4-1BB, CD27, and CD40 correlates with BAP1 aberrancy and prognosis in uveal melanoma	4
Complete response of brainstem metastasis in BRAF-mutated melanoma without stereotactic radiosurgery after initiation of encorafenib and binimetinib	4
COVID-19 vaccination mimicking lymph-node progression in a patient with melanoma: a case report	4
Adjuvant dabrafenib and trametinib for patients with resected BRAF-mutated melanoma: DESCRIBE-AD real-world retrospective observational study	4
Prognostic impact of thyroid dysfunctions on progression-free survival in patients with metastatic melanoma treated with anti-PD-1 antibodies	4
Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era	4
Vitamin D insufficiency and serum levels related to the incidence and stage of cutaneous melanoma: a systematic review and meta-analysis	4
Effectiveness and safety of talimogene laherparepvec and granulocyte-macrophage colony-stimulating factor for metastatic melanoma: a systematic review and network meta-analysis of randomized controlle	4
Molecular profiling of primary uveal melanoma: results of a Polish cohort	3
Seborrheic keratosis-like melanoma: a diagnostic challenge	3
Impact of gene expression profiling on diagnosis and survival after metastasis in patients with uveal melanoma	3
Combination of radiotherapy and targeted therapy for melanoma brain metastases: a systematic review	3
Exploring the clinical significance of specific immune-related adverse events in melanoma patients undergoing immune checkpoint inhibitor therapy	3
The potential of using artificial intelligence to improve skin cancer diagnoses in Hawai‘i’s multiethnic population	3
Clinical and immune correlate results from a phase 1b study of the histone deacetylase inhibitor mocetinostat with ipilimumab and nivolumab in unresectable stage III/IV melanoma	3

Vitiligo-like hypopigmentation induced by dabrafenib-trametinib: a potential marker for clinical response	3
Nivolumab exposure in a hemodialysis patient with metastatic melanoma	3
Treatment outcomes following partial shave biopsy of atypical and malignant melanocytic tumors in pediatric patients	3
Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma	3
Intracranial hemorrhage caused by dabrafenib and trametinib therapy for metastatic melanoma	3
Melanoma risk during immunomodulating treatment	3
The role of wide local excision of a primary lesion in cutaneous malignant melanoma: a retrospective analysis of its usefulness in local and general control of disease	3
Melanomas and mast cells: an ambiguous relationship	3
Treatment experience with encorafenib plus binimetinib for BRAF V600-mutant metastatic melanoma: management insights for clinical practice	3
The effect of COVID-19 on early melanoma detection	3
The combination of PAC-1 and entrectinib for the treatment of metastatic uveal melanoma	3
Efficacy of radiotherapy combined with immune checkpoint inhibitors in patients with melanoma: a systemic review and meta-analysis	3
The number needed to biopsy for cutaneous melanoma in academic dermatology clinics	3
The influence of metastatic patterns and tumor load on therapeutic efficacy of immunotherapy in patients with metastatic melanoma as determined by quantitative PET-parameters using [18F]-fluorodeoxygl	3
The death rate for melanoma remained unchanged in the USA during the coronavirus disease 2019 pandemic	3
Nivolumab-induced immune-mediated acute gastritis in a melanoma patient	3
Do cortisol and psychological distress levels impact the effectiveness of immunotherapy in patients with metastasized melanoma? A pilot study	3
The impact of statins on melanoma survival: a systematic review and meta-analysis	3
Safety of immune checkpoint inhibitors after proton beam therapy in head and neck mucosal melanoma: a case series	3
Ultraviolet A radiation exposure and melanoma: a review	3
Brain metastases during follow-up of patients with resected cutaneous melanoma	3
Tocilizumab in the treatment of steroid refractory immune-related hepatotoxicity: a case series and review of the literature	3
Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma: Erratum	3
Comprehensive clinical imaging, histopathological analysis and liquid biopsy-based surveillance of human uveal melanoma in a prolonged rabbit xenograft model	3
Real-world use and outcomes of targeted therapy and immunotherapy for adjuvant treatment of BRAF-mutated melanoma patients in the United States	2
Efficacy of axitinib in a US cohort of patients with programmed cell death protein 1–resistant mucosal melanoma	2
Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort	2
Clinical characteristics and treatment outcomes of non-V600 E/K BRAF mutant melanoma patients: a single-institution experience	2
Phase II study of apatinib combined with temozolomide in patients with advanced melanoma after failure of immunotherapy	2
Prognostic significance of tumor budding in melanoma	2
Impact of anesthesia choice in cutaneous melanoma surgery	2
Expression of cathepsins B and D by cancer stem cells in head and neck metastatic malignant melanoma	2
Hidden in plain sight: the (other) danger of COVID-19	2
Combined Mcl-1 and YAP1/TAZ inhibition for treatment of metastatic uveal melanoma	2
Liver resection for metastatic uveal melanoma: experience from a supra-regional centre and review of literature	2
Talimogene laherparepvec monotherapy for head and neck melanoma patients	2
Pretreatment CD8+PD-1+ to CD4+PD-1+ ratio is associated with the prognosis of advanced melanoma patients treated with PD-1 inhibitors	2
Cytomegalovirus gastritis as a rare adverse event during combined ipilimumab and nivolumab in a patient with melanoma	2
Relation between dabrafenib plus trametinib-induced pyrexia and age in BRAF V600-mutated metastatic melanoma patients: A post hoc analysis of the real-world ELDERLYMEL study	2
Electrical impedance spectroscopy significantly enhances correct biopsy choice for pigmented skin lesions beyond clinical evaluation and dermoscopy	2
Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors	2
Identification of heterogeneity and prognostic key genes associated with uveal melanoma using single-cell RNA-sequencing technology	2
Definitive treatment with PD-1 blockade and radiation therapy of unresected primary desmoplastic melanoma of the nose	2
Survivals following discontinuation of PD-1 inhibitor treatment in advanced melanoma patients	2
Mucosal melanoma: from molecular landscape to current treatment strategies: Erratum	2
Female melanoma and estrogen receptors expression: an immunohistochemical pilot study	2
Diagnostic and prognostic value of Beclin 1 expression in melanoma: a meta-analysis	2
Association of baseline neutrophil-to-lymphocyte ratio and prognosis in melanoma patients treated with PD-1/PD-L1 blockade: a systematic review and meta-analysis	2
Immunotherapy-induced granulomatous reaction in patients with melanoma	2
Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in skin cutaneous melanoma	2
Pediatric melanoma incidence and survival: a fifteen-year nationwide retrospective cohort study in Korea	2
Sex-dependent interaction of PTGS2 with miR-146a as risk factor for melanoma and the impact of sex hormones in gene expression in skin cells	2
Relationships between survival and real-world recurrence-free survival or distant metastasis-free survival among patients with completely resected stage IIB or IIC melanoma	2
Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis: Erratum	2
Severe blistering eruptions induced by immune checkpoint inhibitors: a multicentre international study of 32 cases	2
The immunologic balance: three cases of rituximab-associated melanoma	2
Cost-effectiveness analysis of an orphan drug-tebentafusp in patients with metastatic uveal melanoma and a call for value-based pricing	2
Challenging pigmented lesions in melanoma patients during checkpoint-inhibitors therapy	2
Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant melanoma	2
Real-life use of trametinib after immunotherapy failure in BRAF wild-type advanced melanoma	2
Clinical and dermoscopical presentation of nivolumab-induced pemphigoid in a metastatic melanoma patient	2
The impact of sentinel lymph node mapping with hybrid single photon emission computed tomography/computed tomography in patients with melanoma. Comparison to planar radioisotopic lymphoscintigraphy	2
Lenalidomide arrests cell cycle and modulates PD1-dependent downstream mTOR intracellular signals in melanoma cells	2
Melanoma cell plasticity poses diagnostic challenges: a case series	1
Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanoma	1
Real-world data on melanoma brain metastases and survival outcome	1
GLI-1 polymorphisms of Hedgehog pathway as novel risk and prognostic biomarkers in melanoma patients	1
Metastatic acral melanoma treatment outcomes: a systematic review and meta-analysis	1
PET-CT for staging pT4b melanomas prior to sentinel lymph node biopsy: a 5-year review	1
Machine learning for the identification of decision boundaries during the transition from radial to vertical growth phase superficial spreading melanomas	1
Real-world healthcare costs of localized and regionally advanced cutaneous melanoma in the Netherlands	1
Influence of regression, its extent and tumor-infiltrating lymphocytes on sentinel node status, relapse, and survival in a 10-year retrospective study of melanoma patients	1
Feasibility of personalized circulating tumor DNA detection in stage II and III melanoma	1
A retrospective study of clinicopathological and prognostic characteristics in 177 Chinese patients with acral melanoma: heterogeneity based on tumor site	1
Efficacy of immune checkpoint inhibition in metastatic uveal melanoma: a systematic review and meta-analysis	1
Patterns of radiological response to tebentafusp in patients with metastatic uveal melanoma	1
Retrospective analysis of adjuvant therapy using dabrafenib plus trametinib in Japanese patients with advanced melanoma: analysis of 36 cases	1
Diagnosis and management of concurrent metastatic melanoma and chronic myelomonocytic leukemia	1
Auto-immune hemolytic anemia and hemophagocytic lymphohistiocytosis as immune-related adverse event in patients with metastatic melanoma and concurrent chronic lymphocytic leukemia: a case series and	1
SIAD onset in a patient affected by metastatic melanoma treated with immune checkpoint inhibitors: the role of nivolumab treatment	1

LINC01063 functions as an oncogene in melanoma through regulation of miR-5194-mediated SOX12 expression	1
Leptomeningeal dissemination as a first sign of progression in metastatic melanoma: a diagnostic lesson	1
Patients with a history of atopy have fewer cutaneous melanomas than those without atopy: a cross-sectional study in 496 patients at risk of skin cancers	1
Regular use of vitamin D supplement is associated with fewer melanoma cases compared to non-use: a cross-sectional study in 498 adult subjects at risk of skin cancers	1
Diffuse large B-cell lymphoma mimicking metastatic melanoma: the importance of biopsies in the era of immune checkpoint inhibitors	1
Tetrasomy of chromosomes 3 and 8 in a young male with choroidal melanoma	1
Successful use of rituximab for refractory hemophagocytic lymphohistiocytosis in a melanoma patient treated with targeted therapy	1
Uncomplicated pregnancy and delivery under ongoing nivolumab therapy for metastatic melanoma	1
The BRAF and NRAS status among distinct metastases of malignant melanoma differ significantly independent of tissue origin and temporal occurrence. Possible effect on clinical relevance?	1
Patient-reported outcomes in randomized controlled trials evaluating BRAF inhibitors in patients with cutaneous melanoma: a systematic scoping review of quality of reporting and trial results	1
Dabrafenib plus trametinib in unselected advanced BRAF V600–mut melanoma: a non-interventional, multicenter, prospective trial	1
Impact of the development of immune related adverse events in metastatic melanoma treated with PD -1 inhibitors	1
Severe treatment-induced inflammatory polyarthritis in advanced melanoma patients: 2 case reports	1
Transcutaneous sentinel lymph node detection in skin melanoma with near-infrared fluorescence imaging using indocyanine green	1
Pregnancy-associated melanoma: characteristics and outcomes from 2002 to 2020	1
Real-world relapse-free survival data on adjuvant anti-PD-1 therapy for patients with newly diagnosed and recurrent stage III melanoma	1
Ultra-high-frequency ultrasound monitoring of melanomas arising in congenital melanocytic nevi: a case series	1
Temporal correlation between the first melanoma and the first noncutaneous tumor in CKDN2A genotyped patients	1
Pembrolizumab-induced hypothyroidism manifesting as myopathy and psychosis	1
Histone deacetylase inhibitor Vorinostat (SAHA) suppresses micropthalmia transcription factor expression and induces cell death in nevocytes from large/giant congenital melanocytic nevi	1
Real-world frequency of BRAF testing and utilization of therapies in patients with advanced melanoma	1
Clinical performance indicators for monitoring the management of cutaneous melanoma: a population-based perspective	1
Correlation of MRI signal characteristics of intracranial melanoma metastases with BRAF mutation status	1
Clinical features of vulvar and vaginal malignant melanomas and the effects of immune checkpoint inhibitors in Japanese patients: a single-center, retrospective cohort study	1
Sequential immunotherapy in melanoma: is it a realistic alternative to dual immunotherapy?	1
The role of osteopontin in the development and metastasis of melanoma	1
Novel strategy for applying hierarchical density-based spatial clustering of applications with noise towards spectroscopic analysis and detection of melanocytic lesions	1
Management of heterogeneous tumor response patterns to immunotherapy in patients with metastatic melanoma	1
Regression of nevi, vitiligo-like depigmentation and halo phenomenon may indicate response to immunotherapy and targeted therapy in melanoma	1
Chemosaturation with percutaneous hepatic perfusion of melphalan for metastatic uveal melanoma	1
Vitiligo-like hypopigmentation secondary to adjuvant checkpoint inhibitor therapy in patients with resectable stage III melanoma: a cohort from two tertiary hospitals	1
Robotic CyberKnife radiosurgery for small choroidal melanomas	1
Reflectance confocal microscopy versus dermoscopy for the diagnosis of cutaneous melanoma: a head-to-head comparative meta-analysis	1
Isolated limb perfusion with melphalan as treatment for regionally advanced melanoma of the limbs: results of 60 patients treated in Finland during 2007–2018	1
Feasibility and efficacy of indocyanine green in monitoring systemic drug leakage during isolated limb perfusion for recurrent melanoma of extremity	1
Assessing melanoma prognosis: the interplay between patient profiles, survival, and BRAF, NRAS, KIT, and TWT mutations in a retrospective multi-study analysis	1
A novel C-terminal Hsp90 inhibitor KU758 synergizes efficacy in combination with BRAF or MEK inhibitors and targets drug-resistant pathways in BRAF-mutant melanomas	1
Combined PDE4+MEK inhibition shows antiproliferative effects in NRAS Q61 mutated melanoma preclinical models	1
Pembrolizumab-induced acquired lipodystrophy: a case report and review of the literature	1
Immunohistochemistry assessment of tissue neutrophil-to-lymphocyte ratio (tNLR) predicts outcomes in melanoma patients treated with anti-programmed cell death 1 therapy	1
Patterns of expression and prognostic implication of glycoprotein nonmetastatic protein B (GPNMB) expression in sentinel lymph nodes of melanoma patients	1
Potential risk factors, clinicopathological features and determinants of survival for multiple primary melanoma patients compared to single primary melanoma: a large single-center Italian study	1
Response of metastatic melanoma with a rare BRAF V600K mutation to dabrafenib and trametinib	1
Melanoma-specific expression of the tumor suppressor proteins p16 and PTEN is a favorable prognostic factor in established melanoma brain metastases	1
A case of hyperprolactinaemia in a patient with metastatic melanoma	1
Expect the unexpected: a saying to bear in mind	1